EquityZen Growth Technology Fund LLC - Series 719
Raised
$2M
Investors
87
Min Invest
$10,000
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 719 is a Delaware-registered pooled investment fund that raised $1.5M from 87 investors under Rule 506(b) and Section 3(c)(1) exemptions, with a $10K minimum investment. Filed December 29, 2020 by EquityZen Advisors and Assure Fund Management II, this vehicle is part of EquityZen's pre-IPO investment platform comprising over 1,800 related entities.
This pre-IPO fund utilizes the standard 506(b)/3(c)(1) exemption pattern for private placement pooled vehicles, with a $10K minimum investment positioning it at the retail-accessible tier of the alternative investment spectrum. The investor count of 87 against a $1.5M raise reflects EquityZen's platform model of aggregating smaller checks (average ~$17K per investor) to access pre-IPO equity.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
